[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Global Midazolam Injection Market Growth 2023-2029

February 2023 | 106 pages | ID: G832779BC9AEEN
LP Information

US$ 3,660.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
The report requires updating with new data and is sent in 48 hours after order is placed.

This medication may also be used to help with anesthesia or to sedate people who need a tube or machine to help with breathing.

LPI (LP Information)' newest research report, the “Midazolam Injection Industry Forecast” looks at past sales and reviews total world Midazolam Injection sales in 2022, providing a comprehensive analysis by region and market sector of projected Midazolam Injection sales for 2023 through 2029. With Midazolam Injection sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Midazolam Injection industry.

This Insight Report provides a comprehensive analysis of the global Midazolam Injection landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Midazolam Injection portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Midazolam Injection market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Midazolam Injection and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Midazolam Injection.

The global Midazolam Injection market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.

United States market for Midazolam Injection is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

China market for Midazolam Injection is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

Europe market for Midazolam Injection is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

Global key Midazolam Injection players cover Akorn, Athenex, Avet Pharmaceuticals, Fresenius Kabi, Hikma, Pfizer, Sun Pharmaceutical, Sandoz and Hameln Pharma, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.

This report presents a comprehensive overview, market shares, and growth opportunities of Midazolam Injection market by product type, application, key manufacturers and key regions and countries.

Market Segmentation:

Segmentation by type
  • 1mg/ml
  • 5mg/ml
Segmentation by application
  • Hospital
  • Clinics
  • Recovery Center
This report also splits the market by region:
  • Americas
    • United States
    • Canada
    • Mexico
    • Brazil
  • APAC
    • China
    • Japan
    • Korea
    • Southeast Asia
    • India
    • Australia
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Russia
  • Middle East & Africa
    • Egypt
    • South Africa
    • Israel
    • Turkey
    • GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
  • Akorn
  • Athenex
  • Avet Pharmaceuticals
  • Fresenius Kabi
  • Hikma
  • Pfizer
  • Sun Pharmaceutical
  • Sandoz
  • Hameln Pharma
  • Yichang Humanwell Pharmaceutical
  • Jiangsu Nhwa Group
Key Questions Addressed in this Report

What is the 10-year outlook for the global Midazolam Injection market?

What factors are driving Midazolam Injection market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Midazolam Injection market opportunities vary by end market size?

How does Midazolam Injection break out type, application?

What are the influences of COVID-19 and Russia-Ukraine war?
1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Midazolam Injection Annual Sales 2018-2029
  2.1.2 World Current & Future Analysis for Midazolam Injection by Geographic Region, 2018, 2022 & 2029
  2.1.3 World Current & Future Analysis for Midazolam Injection by Country/Region, 2018, 2022 & 2029
2.2 Midazolam Injection Segment by Type
  2.2.1 1mg/ml
  2.2.2 5mg/ml
2.3 Midazolam Injection Sales by Type
  2.3.1 Global Midazolam Injection Sales Market Share by Type (2018-2023)
  2.3.2 Global Midazolam Injection Revenue and Market Share by Type (2018-2023)
  2.3.3 Global Midazolam Injection Sale Price by Type (2018-2023)
2.4 Midazolam Injection Segment by Application
  2.4.1 Hospital
  2.4.2 Clinics
  2.4.3 Recovery Center
2.5 Midazolam Injection Sales by Application
  2.5.1 Global Midazolam Injection Sale Market Share by Application (2018-2023)
  2.5.2 Global Midazolam Injection Revenue and Market Share by Application (2018-2023)
  2.5.3 Global Midazolam Injection Sale Price by Application (2018-2023)

3 GLOBAL MIDAZOLAM INJECTION BY COMPANY

3.1 Global Midazolam Injection Breakdown Data by Company
  3.1.1 Global Midazolam Injection Annual Sales by Company (2018-2023)
  3.1.2 Global Midazolam Injection Sales Market Share by Company (2018-2023)
3.2 Global Midazolam Injection Annual Revenue by Company (2018-2023)
  3.2.1 Global Midazolam Injection Revenue by Company (2018-2023)
  3.2.2 Global Midazolam Injection Revenue Market Share by Company (2018-2023)
3.3 Global Midazolam Injection Sale Price by Company
3.4 Key Manufacturers Midazolam Injection Producing Area Distribution, Sales Area, Product Type
  3.4.1 Key Manufacturers Midazolam Injection Product Location Distribution
  3.4.2 Players Midazolam Injection Products Offered
3.5 Market Concentration Rate Analysis
  3.5.1 Competition Landscape Analysis
  3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion

4 WORLD HISTORIC REVIEW FOR MIDAZOLAM INJECTION BY GEOGRAPHIC REGION

4.1 World Historic Midazolam Injection Market Size by Geographic Region (2018-2023)
  4.1.1 Global Midazolam Injection Annual Sales by Geographic Region (2018-2023)
  4.1.2 Global Midazolam Injection Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Midazolam Injection Market Size by Country/Region (2018-2023)
  4.2.1 Global Midazolam Injection Annual Sales by Country/Region (2018-2023)
  4.2.2 Global Midazolam Injection Annual Revenue by Country/Region (2018-2023)
4.3 Americas Midazolam Injection Sales Growth
4.4 APAC Midazolam Injection Sales Growth
4.5 Europe Midazolam Injection Sales Growth
4.6 Middle East & Africa Midazolam Injection Sales Growth

5 AMERICAS

5.1 Americas Midazolam Injection Sales by Country
  5.1.1 Americas Midazolam Injection Sales by Country (2018-2023)
  5.1.2 Americas Midazolam Injection Revenue by Country (2018-2023)
5.2 Americas Midazolam Injection Sales by Type
5.3 Americas Midazolam Injection Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC Midazolam Injection Sales by Region
  6.1.1 APAC Midazolam Injection Sales by Region (2018-2023)
  6.1.2 APAC Midazolam Injection Revenue by Region (2018-2023)
6.2 APAC Midazolam Injection Sales by Type
6.3 APAC Midazolam Injection Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan

7 EUROPE

7.1 Europe Midazolam Injection by Country
  7.1.1 Europe Midazolam Injection Sales by Country (2018-2023)
  7.1.2 Europe Midazolam Injection Revenue by Country (2018-2023)
7.2 Europe Midazolam Injection Sales by Type
7.3 Europe Midazolam Injection Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Midazolam Injection by Country
  8.1.1 Middle East & Africa Midazolam Injection Sales by Country (2018-2023)
  8.1.2 Middle East & Africa Midazolam Injection Revenue by Country (2018-2023)
8.2 Middle East & Africa Midazolam Injection Sales by Type
8.3 Middle East & Africa Midazolam Injection Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 MANUFACTURING COST STRUCTURE ANALYSIS

10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Midazolam Injection
10.3 Manufacturing Process Analysis of Midazolam Injection
10.4 Industry Chain Structure of Midazolam Injection

11 MARKETING, DISTRIBUTORS AND CUSTOMER

11.1 Sales Channel
  11.1.1 Direct Channels
  11.1.2 Indirect Channels
11.2 Midazolam Injection Distributors
11.3 Midazolam Injection Customer

12 WORLD FORECAST REVIEW FOR MIDAZOLAM INJECTION BY GEOGRAPHIC REGION

12.1 Global Midazolam Injection Market Size Forecast by Region
  12.1.1 Global Midazolam Injection Forecast by Region (2024-2029)
  12.1.2 Global Midazolam Injection Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Midazolam Injection Forecast by Type
12.7 Global Midazolam Injection Forecast by Application

13 KEY PLAYERS ANALYSIS

13.1 Akorn
  13.1.1 Akorn Company Information
  13.1.2 Akorn Midazolam Injection Product Portfolios and Specifications
  13.1.3 Akorn Midazolam Injection Sales, Revenue, Price and Gross Margin (2018-2023)
  13.1.4 Akorn Main Business Overview
  13.1.5 Akorn Latest Developments
13.2 Athenex
  13.2.1 Athenex Company Information
  13.2.2 Athenex Midazolam Injection Product Portfolios and Specifications
  13.2.3 Athenex Midazolam Injection Sales, Revenue, Price and Gross Margin (2018-2023)
  13.2.4 Athenex Main Business Overview
  13.2.5 Athenex Latest Developments
13.3 Avet Pharmaceuticals
  13.3.1 Avet Pharmaceuticals Company Information
  13.3.2 Avet Pharmaceuticals Midazolam Injection Product Portfolios and Specifications
  13.3.3 Avet Pharmaceuticals Midazolam Injection Sales, Revenue, Price and Gross Margin (2018-2023)
  13.3.4 Avet Pharmaceuticals Main Business Overview
  13.3.5 Avet Pharmaceuticals Latest Developments
13.4 Fresenius Kabi
  13.4.1 Fresenius Kabi Company Information
  13.4.2 Fresenius Kabi Midazolam Injection Product Portfolios and Specifications
  13.4.3 Fresenius Kabi Midazolam Injection Sales, Revenue, Price and Gross Margin (2018-2023)
  13.4.4 Fresenius Kabi Main Business Overview
  13.4.5 Fresenius Kabi Latest Developments
13.5 Hikma
  13.5.1 Hikma Company Information
  13.5.2 Hikma Midazolam Injection Product Portfolios and Specifications
  13.5.3 Hikma Midazolam Injection Sales, Revenue, Price and Gross Margin (2018-2023)
  13.5.4 Hikma Main Business Overview
  13.5.5 Hikma Latest Developments
13.6 Pfizer
  13.6.1 Pfizer Company Information
  13.6.2 Pfizer Midazolam Injection Product Portfolios and Specifications
  13.6.3 Pfizer Midazolam Injection Sales, Revenue, Price and Gross Margin (2018-2023)
  13.6.4 Pfizer Main Business Overview
  13.6.5 Pfizer Latest Developments
13.7 Sun Pharmaceutical
  13.7.1 Sun Pharmaceutical Company Information
  13.7.2 Sun Pharmaceutical Midazolam Injection Product Portfolios and Specifications
  13.7.3 Sun Pharmaceutical Midazolam Injection Sales, Revenue, Price and Gross Margin (2018-2023)
  13.7.4 Sun Pharmaceutical Main Business Overview
  13.7.5 Sun Pharmaceutical Latest Developments
13.8 Sandoz
  13.8.1 Sandoz Company Information
  13.8.2 Sandoz Midazolam Injection Product Portfolios and Specifications
  13.8.3 Sandoz Midazolam Injection Sales, Revenue, Price and Gross Margin (2018-2023)
  13.8.4 Sandoz Main Business Overview
  13.8.5 Sandoz Latest Developments
13.9 Hameln Pharma
  13.9.1 Hameln Pharma Company Information
  13.9.2 Hameln Pharma Midazolam Injection Product Portfolios and Specifications
  13.9.3 Hameln Pharma Midazolam Injection Sales, Revenue, Price and Gross Margin (2018-2023)
  13.9.4 Hameln Pharma Main Business Overview
  13.9.5 Hameln Pharma Latest Developments
13.10 Yichang Humanwell Pharmaceutical
  13.10.1 Yichang Humanwell Pharmaceutical Company Information
  13.10.2 Yichang Humanwell Pharmaceutical Midazolam Injection Product Portfolios and Specifications
  13.10.3 Yichang Humanwell Pharmaceutical Midazolam Injection Sales, Revenue, Price and Gross Margin (2018-2023)
  13.10.4 Yichang Humanwell Pharmaceutical Main Business Overview
  13.10.5 Yichang Humanwell Pharmaceutical Latest Developments
13.11 Jiangsu Nhwa Group
  13.11.1 Jiangsu Nhwa Group Company Information
  13.11.2 Jiangsu Nhwa Group Midazolam Injection Product Portfolios and Specifications
  13.11.3 Jiangsu Nhwa Group Midazolam Injection Sales, Revenue, Price and Gross Margin (2018-2023)
  13.11.4 Jiangsu Nhwa Group Main Business Overview
  13.11.5 Jiangsu Nhwa Group Latest Developments

14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES

Table 1. Midazolam Injection Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Midazolam Injection Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of 1mg/ml
Table 4. Major Players of 5mg/ml
Table 5. Global Midazolam Injection Sales by Type (2018-2023) & (K Units)
Table 6. Global Midazolam Injection Sales Market Share by Type (2018-2023)
Table 7. Global Midazolam Injection Revenue by Type (2018-2023) & ($ million)
Table 8. Global Midazolam Injection Revenue Market Share by Type (2018-2023)
Table 9. Global Midazolam Injection Sale Price by Type (2018-2023) & (US$/Unit)
Table 10. Global Midazolam Injection Sales by Application (2018-2023) & (K Units)
Table 11. Global Midazolam Injection Sales Market Share by Application (2018-2023)
Table 12. Global Midazolam Injection Revenue by Application (2018-2023)
Table 13. Global Midazolam Injection Revenue Market Share by Application (2018-2023)
Table 14. Global Midazolam Injection Sale Price by Application (2018-2023) & (US$/Unit)
Table 15. Global Midazolam Injection Sales by Company (2018-2023) & (K Units)
Table 16. Global Midazolam Injection Sales Market Share by Company (2018-2023)
Table 17. Global Midazolam Injection Revenue by Company (2018-2023) ($ Millions)
Table 18. Global Midazolam Injection Revenue Market Share by Company (2018-2023)
Table 19. Global Midazolam Injection Sale Price by Company (2018-2023) & (US$/Unit)
Table 20. Key Manufacturers Midazolam Injection Producing Area Distribution and Sales Area
Table 21. Players Midazolam Injection Products Offered
Table 22. Midazolam Injection Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Midazolam Injection Sales by Geographic Region (2018-2023) & (K Units)
Table 26. Global Midazolam Injection Sales Market Share Geographic Region (2018-2023)
Table 27. Global Midazolam Injection Revenue by Geographic Region (2018-2023) & ($ millions)
Table 28. Global Midazolam Injection Revenue Market Share by Geographic Region (2018-2023)
Table 29. Global Midazolam Injection Sales by Country/Region (2018-2023) & (K Units)
Table 30. Global Midazolam Injection Sales Market Share by Country/Region (2018-2023)
Table 31. Global Midazolam Injection Revenue by Country/Region (2018-2023) & ($ millions)
Table 32. Global Midazolam Injection Revenue Market Share by Country/Region (2018-2023)
Table 33. Americas Midazolam Injection Sales by Country (2018-2023) & (K Units)
Table 34. Americas Midazolam Injection Sales Market Share by Country (2018-2023)
Table 35. Americas Midazolam Injection Revenue by Country (2018-2023) & ($ Millions)
Table 36. Americas Midazolam Injection Revenue Market Share by Country (2018-2023)
Table 37. Americas Midazolam Injection Sales by Type (2018-2023) & (K Units)
Table 38. Americas Midazolam Injection Sales by Application (2018-2023) & (K Units)
Table 39. APAC Midazolam Injection Sales by Region (2018-2023) & (K Units)
Table 40. APAC Midazolam Injection Sales Market Share by Region (2018-2023)
Table 41. APAC Midazolam Injection Revenue by Region (2018-2023) & ($ Millions)
Table 42. APAC Midazolam Injection Revenue Market Share by Region (2018-2023)
Table 43. APAC Midazolam Injection Sales by Type (2018-2023) & (K Units)
Table 44. APAC Midazolam Injection Sales by Application (2018-2023) & (K Units)
Table 45. Europe Midazolam Injection Sales by Country (2018-2023) & (K Units)
Table 46. Europe Midazolam Injection Sales Market Share by Country (2018-2023)
Table 47. Europe Midazolam Injection Revenue by Country (2018-2023) & ($ Millions)
Table 48. Europe Midazolam Injection Revenue Market Share by Country (2018-2023)
Table 49. Europe Midazolam Injection Sales by Type (2018-2023) & (K Units)
Table 50. Europe Midazolam Injection Sales by Application (2018-2023) & (K Units)
Table 51. Middle East & Africa Midazolam Injection Sales by Country (2018-2023) & (K Units)
Table 52. Middle East & Africa Midazolam Injection Sales Market Share by Country (2018-2023)
Table 53. Middle East & Africa Midazolam Injection Revenue by Country (2018-2023) & ($ Millions)
Table 54. Middle East & Africa Midazolam Injection Revenue Market Share by Country (2018-2023)
Table 55. Middle East & Africa Midazolam Injection Sales by Type (2018-2023) & (K Units)
Table 56. Middle East & Africa Midazolam Injection Sales by Application (2018-2023) & (K Units)
Table 57. Key Market Drivers & Growth Opportunities of Midazolam Injection
Table 58. Key Market Challenges & Risks of Midazolam Injection
Table 59. Key Industry Trends of Midazolam Injection
Table 60. Midazolam Injection Raw Material
Table 61. Key Suppliers of Raw Materials
Table 62. Midazolam Injection Distributors List
Table 63. Midazolam Injection Customer List
Table 64. Global Midazolam Injection Sales Forecast by Region (2024-2029) & (K Units)
Table 65. Global Midazolam Injection Revenue Forecast by Region (2024-2029) & ($ millions)
Table 66. Americas Midazolam Injection Sales Forecast by Country (2024-2029) & (K Units)
Table 67. Americas Midazolam Injection Revenue Forecast by Country (2024-2029) & ($ millions)
Table 68. APAC Midazolam Injection Sales Forecast by Region (2024-2029) & (K Units)
Table 69. APAC Midazolam Injection Revenue Forecast by Region (2024-2029) & ($ millions)
Table 70. Europe Midazolam Injection Sales Forecast by Country (2024-2029) & (K Units)
Table 71. Europe Midazolam Injection Revenue Forecast by Country (2024-2029) & ($ millions)
Table 72. Middle East & Africa Midazolam Injection Sales Forecast by Country (2024-2029) & (K Units)
Table 73. Middle East & Africa Midazolam Injection Revenue Forecast by Country (2024-2029) & ($ millions)
Table 74. Global Midazolam Injection Sales Forecast by Type (2024-2029) & (K Units)
Table 75. Global Midazolam Injection Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 76. Global Midazolam Injection Sales Forecast by Application (2024-2029) & (K Units)
Table 77. Global Midazolam Injection Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 78. Akorn Basic Information, Midazolam Injection Manufacturing Base, Sales Area and Its Competitors
Table 79. Akorn Midazolam Injection Product Portfolios and Specifications
Table 80. Akorn Midazolam Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 81. Akorn Main Business
Table 82. Akorn Latest Developments
Table 83. Athenex Basic Information, Midazolam Injection Manufacturing Base, Sales Area and Its Competitors
Table 84. Athenex Midazolam Injection Product Portfolios and Specifications
Table 85. Athenex Midazolam Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 86. Athenex Main Business
Table 87. Athenex Latest Developments
Table 88. Avet Pharmaceuticals Basic Information, Midazolam Injection Manufacturing Base, Sales Area and Its Competitors
Table 89. Avet Pharmaceuticals Midazolam Injection Product Portfolios and Specifications
Table 90. Avet Pharmaceuticals Midazolam Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 91. Avet Pharmaceuticals Main Business
Table 92. Avet Pharmaceuticals Latest Developments
Table 93. Fresenius Kabi Basic Information, Midazolam Injection Manufacturing Base, Sales Area and Its Competitors
Table 94. Fresenius Kabi Midazolam Injection Product Portfolios and Specifications
Table 95. Fresenius Kabi Midazolam Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 96. Fresenius Kabi Main Business
Table 97. Fresenius Kabi Latest Developments
Table 98. Hikma Basic Information, Midazolam Injection Manufacturing Base, Sales Area and Its Competitors
Table 99. Hikma Midazolam Injection Product Portfolios and Specifications
Table 100. Hikma Midazolam Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 101. Hikma Main Business
Table 102. Hikma Latest Developments
Table 103. Pfizer Basic Information, Midazolam Injection Manufacturing Base, Sales Area and Its Competitors
Table 104. Pfizer Midazolam Injection Product Portfolios and Specifications
Table 105. Pfizer Midazolam Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 106. Pfizer Main Business
Table 107. Pfizer Latest Developments
Table 108. Sun Pharmaceutical Basic Information, Midazolam Injection Manufacturing Base, Sales Area and Its Competitors
Table 109. Sun Pharmaceutical Midazolam Injection Product Portfolios and Specifications
Table 110. Sun Pharmaceutical Midazolam Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 111. Sun Pharmaceutical Main Business
Table 112. Sun Pharmaceutical Latest Developments
Table 113. Sandoz Basic Information, Midazolam Injection Manufacturing Base, Sales Area and Its Competitors
Table 114. Sandoz Midazolam Injection Product Portfolios and Specifications
Table 115. Sandoz Midazolam Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 116. Sandoz Main Business
Table 117. Sandoz Latest Developments
Table 118. Hameln Pharma Basic Information, Midazolam Injection Manufacturing Base, Sales Area and Its Competitors
Table 119. Hameln Pharma Midazolam Injection Product Portfolios and Specifications
Table 120. Hameln Pharma Midazolam Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 121. Hameln Pharma Main Business
Table 122. Hameln Pharma Latest Developments
Table 123. Yichang Humanwell Pharmaceutical Basic Information, Midazolam Injection Manufacturing Base, Sales Area and Its Competitors
Table 124. Yichang Humanwell Pharmaceutical Midazolam Injection Product Portfolios and Specifications
Table 125. Yichang Humanwell Pharmaceutical Midazolam Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 126. Yichang Humanwell Pharmaceutical Main Business
Table 127. Yichang Humanwell Pharmaceutical Latest Developments
Table 128. Jiangsu Nhwa Group Basic Information, Midazolam Injection Manufacturing Base, Sales Area and Its Competitors
Table 129. Jiangsu Nhwa Group Midazolam Injection Product Portfolios and Specifications
Table 130. Jiangsu Nhwa Group Midazolam Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 131. Jiangsu Nhwa Group Main Business
Table 132. Jiangsu Nhwa Group Latest Developments

LIST OF FIGURES

Figure 1. Picture of Midazolam Injection
Figure 2. Midazolam Injection Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Midazolam Injection Sales Growth Rate 2018-2029 (K Units)
Figure 7. Global Midazolam Injection Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Midazolam Injection Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of 1mg/ml
Figure 10. Product Picture of 5mg/ml
Figure 11. Global Midazolam Injection Sales Market Share by Type in 2022
Figure 12. Global Midazolam Injection Revenue Market Share by Type (2018-2023)
Figure 13. Midazolam Injection Consumed in Hospital
Figure 14. Global Midazolam Injection Market: Hospital (2018-2023) & (K Units)
Figure 15. Midazolam Injection Consumed in Clinics
Figure 16. Global Midazolam Injection Market: Clinics (2018-2023) & (K Units)
Figure 17. Midazolam Injection Consumed in Recovery Center
Figure 18. Global Midazolam Injection Market: Recovery Center (2018-2023) & (K Units)
Figure 19. Global Midazolam Injection Sales Market Share by Application (2022)
Figure 20. Global Midazolam Injection Revenue Market Share by Application in 2022
Figure 21. Midazolam Injection Sales Market by Company in 2022 (K Units)
Figure 22. Global Midazolam Injection Sales Market Share by Company in 2022
Figure 23. Midazolam Injection Revenue Market by Company in 2022 ($ Million)
Figure 24. Global Midazolam Injection Revenue Market Share by Company in 2022
Figure 25. Global Midazolam Injection Sales Market Share by Geographic Region (2018-2023)
Figure 26. Global Midazolam Injection Revenue Market Share by Geographic Region in 2022
Figure 27. Americas Midazolam Injection Sales 2018-2023 (K Units)
Figure 28. Americas Midazolam Injection Revenue 2018-2023 ($ Millions)
Figure 29. APAC Midazolam Injection Sales 2018-2023 (K Units)
Figure 30. APAC Midazolam Injection Revenue 2018-2023 ($ Millions)
Figure 31. Europe Midazolam Injection Sales 2018-2023 (K Units)
Figure 32. Europe Midazolam Injection Revenue 2018-2023 ($ Millions)
Figure 33. Middle East & Africa Midazolam Injection Sales 2018-2023 (K Units)
Figure 34. Middle East & Africa Midazolam Injection Revenue 2018-2023 ($ Millions)
Figure 35. Americas Midazolam Injection Sales Market Share by Country in 2022
Figure 36. Americas Midazolam Injection Revenue Market Share by Country in 2022
Figure 37. Americas Midazolam Injection Sales Market Share by Type (2018-2023)
Figure 38. Americas Midazolam Injection Sales Market Share by Application (2018-2023)
Figure 39. United States Midazolam Injection Revenue Growth 2018-2023 ($ Millions)
Figure 40. Canada Midazolam Injection Revenue Growth 2018-2023 ($ Millions)
Figure 41. Mexico Midazolam Injection Revenue Growth 2018-2023 ($ Millions)
Figure 42. Brazil Midazolam Injection Revenue Growth 2018-2023 ($ Millions)
Figure 43. APAC Midazolam Injection Sales Market Share by Region in 2022
Figure 44. APAC Midazolam Injection Revenue Market Share by Regions in 2022
Figure 45. APAC Midazolam Injection Sales Market Share by Type (2018-2023)
Figure 46. APAC Midazolam Injection Sales Market Share by Application (2018-2023)
Figure 47. China Midazolam Injection Revenue Growth 2018-2023 ($ Millions)
Figure 48. Japan Midazolam Injection Revenue Growth 2018-2023 ($ Millions)
Figure 49. South Korea Midazolam Injection Revenue Growth 2018-2023 ($ Millions)
Figure 50. Southeast Asia Midazolam Injection Revenue Growth 2018-2023 ($ Millions)
Figure 51. India Midazolam Injection Revenue Growth 2018-2023 ($ Millions)
Figure 52. Australia Midazolam Injection Revenue Growth 2018-2023 ($ Millions)
Figure 53. China Taiwan Midazolam Injection Revenue Growth 2018-2023 ($ Millions)
Figure 54. Europe Midazolam Injection Sales Market Share by Country in 2022
Figure 55. Europe Midazolam Injection Revenue Market Share by Country in 2022
Figure 56. Europe Midazolam Injection Sales Market Share by Type (2018-2023)
Figure 57. Europe Midazolam Injection Sales Market Share by Application (2018-2023)
Figure 58. Germany Midazolam Injection Revenue Growth 2018-2023 ($ Millions)
Figure 59. France Midazolam Injection Revenue Growth 2018-2023 ($ Millions)
Figure 60. UK Midazolam Injection Revenue Growth 2018-2023 ($ Millions)
Figure 61. Italy Midazolam Injection Revenue Growth 2018-2023 ($ Millions)
Figure 62. Russia Midazolam Injection Revenue Growth 2018-2023 ($ Millions)
Figure 63. Middle East & Africa Midazolam Injection Sales Market Share by Country in 2022
Figure 64. Middle East & Africa Midazolam Injection Revenue Market Share by Country in 2022
Figure 65. Middle East & Africa Midazolam Injection Sales Market Share by Type (2018-2023)
Figure 66. Middle East & Africa Midazolam Injection Sales Market Share by Application (2018-2023)
Figure 67. Egypt Midazolam Injection Revenue Growth 2018-2023 ($ Millions)
Figure 68. South Africa Midazolam Injection Revenue Growth 2018-2023 ($ Millions)
Figure 69. Israel Midazolam Injection Revenue Growth 2018-2023 ($ Millions)
Figure 70. Turkey Midazolam Injection Revenue Growth 2018-2023 ($ Millions)
Figure 71. GCC Country Midazolam Injection Revenue Growth 2018-2023 ($ Millions)
Figure 72. Manufacturing Cost Structure Analysis of Midazolam Injection in 2022
Figure 73. Manufacturing Process Analysis of Midazolam Injection
Figure 74. Industry Chain Structure of Midazolam Injection
Figure 75. Channels of Distribution
Figure 76. Global Midazolam Injection Sales Market Forecast by Region (2024-2029)
Figure 77. Global Midazolam Injection Revenue Market Share Forecast by Region (2024-2029)
Figure 78. Global Midazolam Injection Sales Market Share Forecast by Type (2024-2029)
Figure 79. Global Midazolam Injection Revenue Market Share Forecast by Type (2024-2029)
Figure 80. Global Midazolam Injection Sales Market Share Forecast by Application (2024-2029)
Figure 81. Global Midazolam Injection Revenue Market Share Forecast by Application (2024-2029)


More Publications